Logo-ipp
Submitted: 01 Aug 2020
Accepted: 08 Aug 2020
ePublished: 12 Aug 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Immunopathol Persa. 2021;7(2): e12.
doi: 10.34172/ipp.2021.12
  Abstract View: 164
  PDF Download: 85

Editorial

Controversy with bromhexine in COVID-19; where we stand

Ramin Tolouian 1 * ORCID logo, Zuber D. Mulla 2 ORCID logo

1 Division of Nephrology, University of Arizona, Tucson, AZ, USA
2 Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA, and Julia Jones Matthews Department of Public Health, Texas Tech University Health Sciences Center, Lubbock, TX, USA
Correspondence to Prof. Ramin Tolouian, Email; Ramin.tolouian@va.gov
Keywords: Bromhexine, COVID-19, TMPRSS2, SARS-CoV-2
Citation: Tolouian R , Mulla ZD. Controversy with bromhexine in COVID-19; where we stand. Immunopathol Persa. 2021;7(2):e12. DOI:10.34172/ ipp.2021.12.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 164

Your browser does not support the canvas element.


PDF Download: 85

Your browser does not support the canvas element.